The LifeZig system, developed by Photozig, Inc., targets the Alzheimer's disease and dementia market, which is experiencing significant growth due to the aging population. The intervention aims to improve the quality of life for patients and reduce caregiver burden, positioning it as a supportive care solution. The competitive landscape includes traditional reminiscence therapies and other cognitive engagement tools. Given the increasing prevalence of dementia, this asset could capture a substantial market share if proven effective. Diligence should focus on reimbursement pathways, potential partnerships with healthcare providers, and scalability of the technology.